Corrigendum to “Efficacy, safety and moderating factors of repetitive transcranial magnetic stimulation in post-traumatic stress disorder: A systematic review and meta-analysis” [Prog. Neuro-Psychopharmacol. Biol. Psychiatry 149 (2026) 111912]
Corrigendum to “Efficacy, safety and moderating factors of repetitive transcranial magnetic stimulation in post-traumatic stress disorder: A systematic review and meta-analysis” [Prog. Neuro-Psychopharmacol. Biol. Psychiatry 149 (2026) 111912]. // Progress in Neuro-Psychopharmacology & Biological Psychiatry. – URL: https://www.sciencedirect.com/science/article/pii/S0278584626003362?dgcid=rss_sd_all
Corrigendum to “Efficacy, safety and moderating factors of repetitive transcranial magnetic stimulation in post-traumatic stress disorder: A systematic review and meta-analysis” [Prog. Neuro-Psychopharmacol. Biol. Psychiatry 149 (2026) 111912]. Progress in Neuro-Psychopharmacology & Biological Psychiatry. https://www.sciencedirect.com/science/article/pii/S0278584626003362?dgcid=rss_sd_all
“Corrigendum to “Efficacy, safety and moderating factors of repetitive transcranial magnetic stimulation in post-traumatic stress disorder: A systematic review and meta-analysis” [Prog. Neuro-Psychopharmacol. Biol. Psychiatry 149 (2026) 111912].” Progress in Neuro-Psychopharmacology & Biological Psychiatry.
@article{article62918,
title = {Corrigendum to “Efficacy, safety and moderating factors of repetitive transcranial magnetic stimulation in post-traumatic stress disorder: A systematic review and meta-analysis” [Prog. Neuro-Psychopharmacol. Biol. Psychiatry 149 (2026) 111912]},
journal = {Progress in Neuro-Psychopharmacology \& Biological Psychiatry},
url = {https://www.sciencedirect.com/science/article/pii/S0278584626003362?dgcid=rss_sd_all}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...